drugset / Trial / NCT04073303

BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence

NCT04073303

Phase 3 Completed 377 enrolled AbbVie
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to evaluate the safety and effectiveness of administering BOTOX for the treatment of Masseter Muscle Prominence (MMP) in adults.

Timeline

Start
2019-08-29
Primary completion
2022-11-10
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic Intramuscular